💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @ResearchPool | 3 |
| @MikesChannelB | 1 |
| @SolomonDoug | 1 |
| @Pharming_Eric | 1 |
| @askwarrenbuffet | 1 |
Recent Tweets for IMMU
 |
@Pharming_Eric @DuaneReadeSanta $immu comparison is a bold one! 1:09am |
 |
@SolomonDoug @JacobPlieth $gild and $immu looks interesting . September 16th 2021, 9:09am |
 |
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/ejGqGz1akD September 15th 2021, 12:09pm |
 |
@MikesChannelB RT @ResearchPool: $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime in Dece… September 14th 2021, 1:09pm |
|
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/YOzzijSbmH September 14th 2021, 1:09pm |
|
@ResearchPool $IMMU #Immunicum AB Immunicum - Primed for value appreciation: Following the transformational merger with DCprime i… https://t.co/x16QNYpi1h September 14th 2021, 1:09pm |
 |
@SenateBiPartisN @ej23ny I remember $immu , are you kidding me given the price tag sold for, so yes point well-taken. I’ve had a cou… https://t.co/Nvs8KgWShp September 11th 2021, 2:09am |
 |
@biotechradar_eu Immunicum $IMMU and the University Medical Center Groningen Receive a Grant from Health~Holland to Broaden Cancer R… https://t.co/woOEf1TJL5 September 8th 2021, 6:09am |
 |
@askwarrenbuffet $CYDY CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/1I6R2I4dZd September 5th 2021, 3:09am |
 |
@outremer511 @Biohazard3737 Speaking of $IMMU, if anyone knows what @behzadAghazadeh is doing these days please post. September 2nd 2021, 10:09pm |
|
@askwarrenbuffet $AMC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/fMu7wjkQm3 August 29th 2021, 1:08am |
|
@biotechradar_eu Immunicum $IMMU Announces Participation in Multiple Upcoming Industry and Investor Events in September and October https://t.co/fvpq7f6GoF August 27th 2021, 9:08am |
 |
@Redeye_ Our analyst comments on Immunicum's Q2 report and expected upcoming news flow: $IMMU https://t.co/UXr84YrQ8h August 26th 2021, 10:08pm |
 |
@Biohazard3737 @BioChaff Will probably continue to trade like death for a few days, if recent high premium deals like $IMMU are in… https://t.co/hDNsKIfzSt August 23rd 2021, 2:08pm |
|
@askwarrenbuffet $HMBL CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/1f5Ycjo7OA August 11th 2021, 12:08am |
 |
@DavidNYC1993 @haodongvli $IMMU vs $AXSM ? 2 different types of tracks,,, right ? August 9th 2021, 8:08pm |
|
@askwarrenbuffet $CSOC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/kJ3OE2upB1 August 8th 2021, 2:08am |
|
@askwarrenbuffet $RIOT CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/yHrhaq1jtF August 8th 2021, 12:08am |
 |
@FContrarian $AUPH @jimcramer Does it again. Remember $IMMU ? deja vu ! August 6th 2021, 6:08pm |
 |
@FinTaxBot RT @StockTipRobot: My random stock tip generator says shift all your savings into Immunomedics $IMMU #StockMarket August 4th 2021, 12:08pm |
 |
@StockTipRobot My random stock tip generator says shift all your savings into Immunomedics $IMMU #StockMarket August 4th 2021, 12:08pm |
|
@askwarrenbuffet $ATMH CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/4DfEDwQhwx August 3rd 2021, 11:08pm |
 |
@CharlesStonkson Like $MRNA and $IMMU Adam Feurstein is displaying his obvious allegiance to big pharma and short sellers…of course… https://t.co/Y7e7FSufL9 August 1st 2021, 7:08pm |
 |
@PaulTorresCohen Paul Torres-Cohen $IMMU August 1st 2021, 1:08am |
 |
@deriver51745581 $IMMU - Immunicum Breakout ?? Significant Catalysts Ahead Q3 & Q4 #finanstwitter #fintwit #aktier… https://t.co/1CljlrJSUB July 27th 2021, 8:07pm |
 |
@ExemplariskB $IMMU ?? July 27th 2021, 2:07pm |
|
@biotechradar_eu Immunicum $IMMU Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD Study https://t.co/b7UeAabtsY July 26th 2021, 6:07am |
|
@deriver51745581 $IMMU - Immunicum Immunicum Announces Positive Review by Data Safety Monitoring Board for Phase Ib Part of ILIAD… https://t.co/HitOj2cvjz July 26th 2021, 6:07am |
 |
@oakazaki @DammitJean @buysidebio May want to update that list $OGN is women’s health. $IMMU gone. Amongst others. July 21st 2021, 9:07pm |
|
@askwarrenbuffet $RXMD CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/zcPSR9RiKh July 21st 2021, 12:07am |
|
@askwarrenbuffet $CRM CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUrTi2 $IMMU… https://t.co/aFQuah5AqU July 19th 2021, 1:07am |
 |
@JacobPlieth Adcendo (Uni of Copenhagen spin-out focusing on ADCs) just appointed former $IMMU head as CEO. €51m series A raised this year. July 7th 2021, 1:07pm |
|
@biotechradar_eu Immunicum $IMMU Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine… https://t.co/uVO3GIKK8V June 28th 2021, 6:06am |
 |
@STARS_Alpha2236 @FentonLounge How many $IMMU shares were bought out versus how many $ENZC shares would need to be purchased? Sorry… https://t.co/GogsBkYKQM June 26th 2021, 11:06am |
|
@deriver51745581 $IMMU - Immunicum Significant Catalysts Ahead 1. Phase Ib ILIAD trial for ilixadencel in combination with Keytrud… https://t.co/sg5Ce6TEbM June 24th 2021, 10:06am |
 |
@newsfilterio Immunomedics Gets Early FDA Approval - Path To Profitability Still Treacherous $CYDY $IMMU https://t.co/N1hSvmihbQ June 24th 2021, 9:06am |
|
@biotechradar_eu Immunicum $IMMU Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Can… https://t.co/5xJPsGUrs9 June 23rd 2021, 10:06am |
 |
@GT20216 @BurchetJohn @lifeofhp Thanks! Somehow, I can’t find the ticker $IMMU ?? June 19th 2021, 12:06pm |
 |
@BurchetJohn @GT20216 @lifeofhp $immu https://t.co/giMRjXd4vN June 19th 2021, 12:06pm |
|
@GT20216 @BurchetJohn @lifeofhp May I ask why $IMMU? June 19th 2021, 11:06am |
|
@Redeye_ Redeye regards the capital raise as an expected and logical step for Immunicum. Read our analyst's take: $IMMU https://t.co/xS3gepDFsr June 18th 2021, 8:06am |
|
@biotechradar_eu Immunicum $IMMU Announces Results of Directed Share Issue https://t.co/ZK5iCyo56r June 17th 2021, 8:06pm |
|
@biotechradar_eu Immunicum $IMMU Announces its Intention to Carry Out a Directed Share Issue https://t.co/sRiipKivMl June 17th 2021, 3:06pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?